Photo illustration of somone holding up a luighbubl with a coin inside. The background is yellow with abstract black and green rectangles. -- biotech coverage from STAT
Adobe

By Allison DeAngelis

Dec. 5, 2024

Biotech Startups and Venture Capital Reporter

Atlas Venture, one of the leading venture capital firms in the biotech industry, has raised $450 million for a new fund, the firm’s leaders told STAT exclusively. 

The fund — Atlas’ 14th — will go towards seed and series A rounds for biotech companies, most of which the firm will have a hand in creating. Atlas rarely takes outside pitches from entrepreneurs, though it will sometimes team up with other VC firms that have launched a new startup.  

advertisement

The news comes just a few weeks after Partner Bruce Booth mentioned that the firm was raising the fund during his annual “year-in-review” video presentation.

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$20

for 3 months, then $399/year

$20 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe
, ,
Submit a correction requestReprints

  1. Allison DeAngelis

    Biotech Startups and Venture Capital Reporter

    Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.